Treatment: Life saving subsidy for cancer drug

Thousands of Australian cancer patients will be given a new shot at life under a $1.1 billion package handing them access to a breakthrough drug. Under one of the biggest ever listings on the Pharmaceutical Benefits Scheme, Opdivo will be made available to lung and kidney cancer patients. From August 1, about 4500 cancer patients a year will be able to access the groundbreaking drug currently worth $130,000 a year for just $38.80 a treatment under the Federal Government subsidy. The Sunday Times, 30 July 2017, page 9; The Sunday Territorian, 30 July 2017, page 1; The Sunday Mail Adelaide, 30 July 2017, page 12; The Sunday Tasmanian, 30 July 2017, page 2; The Sunday Mail Brisbane, 30 July 2017, page 21; The Sunday Mail Adelaide, 30 July 2017, page 68; The Sunday Telegraph, 30 July 2017, page 5; The Sunday Herald Sun, 30 July 2017, page 1; The Australian Financial Review, 31 July 2017, page 2; The Hobart Mercury, 31 July 2017, page 3

#Treatment #Cancer #Opdivo #LungCancer #KidneyCancer